Aurobindo Pharma Limited (BOM:524804)
1,247.80
+59.70 (5.02%)
At close: Apr 23, 2025
Aurobindo Pharma Employees
Aurobindo Pharma had 26,015 employees as of March 31, 2024. The number of employees increased by 2,564 or 10.93% compared to the previous year.
Employees
26,015
Change (1Y)
2,564
Growth (1Y)
10.93%
Revenue / Employee
11.89M INR
Profits / Employee
1.34M INR
Market Cap
730.53B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Reliance Industries | 347,362 |
HDFC Bank | 213,527 |
Tata Consultancy Services | 607,979 |
Bharti Airtel | 23,628 |
ICICI Bank | 187,765 |
State Bank of India | 232,296 |
Infosys | 317,240 |
Bajaj Finance | 43,147 |
Aurobindo Pharma News
- 9 days ago - Aurobindo Pharma gains over 2.5% after USFDA nod for Rivaroxaban tablets in $8.5 billion US market - Business Upturn
- 9 days ago - Top stocks to watch today, April 15: HDFC Bank, Tata Power, Cyient, IRCON, Vedanta, Aurobindo Pharma and more - Business Upturn
- 9 days ago - Stocks to watch today: Zydus, Aurobindo, HCL Tech, Tata Power, Indian Hotels, Cyient in focus on expansion and global deals - Business Upturn
- 13 days ago - Aurobindo Pharma subsidiary receives 11 USFDA observations after North Carolina facility inspection - Business Upturn
- 13 days ago - Aurobindo Pharma shares surge over 3% as subsidiary CuraTeQ Biologics reports successful trial results for bone drug BP16 - Business Upturn
- 13 days ago - Top stocks to watch today, April 11: Tata Steel, Infosys, TCS, BHEL, Aurobindo Pharma, Biocon and more - Business Upturn
- 15 days ago - Pharma Stocks Falls: Aurobindo Pharma slips 2%, Lupin down 2%, Divi’s Labs falls 3% as Trump reiterates tariffs on pharmaceuticals ‘soon’ - Business Upturn
- 19 days ago - Aurobindo Pharma subsidiary secures EU approval for Dyrupeg, a pegylated filgrastim biosimilar - Business Upturn